MDxHealth
MDxHealth is a molecular diagnostics company focused on developing and commercializing advanced tests for cancer assessment and personalized treatment. The company offers a range of products including ConfirmMDx, a prostate cancer testing solution that addresses false-negative biopsy concerns; SelectMDx, which helps guide repeat biopsies for prostate cancer; and AssureMDx, a noninvasive liquid biopsy test for bladder cancer that assists in decision-making for cystoscopy. Additionally, MDxHealth provides PredictMDx for Glioblastoma, a tissue methylation test that aids in treatment decisions for brain cancer. Founded in 2003 and headquartered in Irvine, California, MDxHealth operates additional offices in Herstal, Belgium, and Nijmegen, the Netherlands. The company generates revenue through clinical laboratory services and the out-licensing of its patented DNA methylation platform and biomarkers, serving markets in the United States and Europe.
Exact Sciences’ Precision Oncology portfolio of genomic tests provide physicians and patients with personalized insights about the patient’s tumor, allowing them to make treatment decisions with a greater degree of confidence.
NovioGendix is a privately-held molecular diagnostics company based in Nijmegen, The Netherlands, specializing in the development of non-invasive liquid biopsy tests for prostate cancer. Established in 2008 as a spin-off from Radboud University Medical Center, NovioGendix collaborates closely with various departments of the institution. The company is focused on creating advanced and clinically relevant molecular diagnostic assays for uro-oncological practices, and it has a portfolio of diagnostic tests for prostate, bladder, kidney, and other urologic cancers at different stages of development. NovioGendix provides its services to physicians, clinics, and hospitals, aiming to enhance cancer treatment through innovative diagnostic solutions. Major shareholders include BioGeneration Ventures and Participatiemaatschappij Oost Nederland.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.